Misleading advertising for antidepressants in sweden: a failure of pharmaceutical industry self-regulation.

Summary, in English

The alleged efficacy of pharmaceutical industry self-regulation has been used to repudiate increased government oversight over promotional activity. European politicians and industry have cited Sweden as an excellent example of self-regulation based on an ethical code. This paper considers antidepressant advertising in Sweden to uncover the strengths and weaknesses of self-regulation.

• Författare: Anna Zetterqvist; Shai Mulinari
• Avdelning/ar: Kardiovaskulär forskning - immunitet och ateroskleros; Diabetiska komplikationer; Genusvetenskapliga institutionen; EXODIAB: Excellence of Diabetes Research in Sweden
• Publiceringsår: 2013
• Språk: Engelska
• Publikation/Tidskrift/Serie: PLoS ONE
• Volym: 8
• Issue: 5
• Fulltext: - 611 kB; Download statistics
• Länkar: http://www.ncbi.nlm.nih.gov/pubmed/23650519?dopt=Abstract; http://dx.doi.org/10.1371/journal.pone.0062609
• Dokumenttyp: Artikel i tidskrift
• Förlag: Public Library of Science (PLoS)
• Ämne: Health Care Service and Management, Health Policy and Services and Health Economy
• Nyckelord: Advertising; Antidepressants; Drug Industry; Sweden; Codes of ethics
• Status: Published
• Projekt: After the success with the new generation antidepressants: Experiences, practices, discourses and changes in the self.
• Forskningsgrupp: Cardiovascular Research - Immunity and Atherosclerosis; Diabetic Complications
• ISBN/ISSN/Övrigt: ISSN: 1932-6203